View in EDS HTML Full Text PDF Full Text

Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.
Authors: Nguyen TTH; College of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, R3E0T5, Canada., Mital S; College of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, R3E0T5, Canada. shweta.mital@umanitoba.ca.
Source: PharmacoEconomics [Pharmacoeconomics] 2025 Mar; Vol. 43 (3), pp. 351-361. Date of Electronic Publication: 2024 Dec 04.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39630382
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nguyen+TTH%22">Nguyen TTH</searchLink>; College of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, R3E0T5, Canada.<br /><searchLink fieldCode="AU" term="%22Mital+S%22">Mital S</searchLink>; College of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, R3E0T5, Canada. shweta.mital@umanitoba.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2025 Mar; Vol. 43 (3), pp. 351-361. <i>Date of Electronic Publication: </i>2024 Dec 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39630382
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40273-024-01456-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 351
    Titles:
      – TitleFull: Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nguyen TTH
      – PersonEntity:
          Name:
            NameFull: Mital S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2027
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: PharmacoEconomics
              Type: main
ResultId 1